scholarly article | Q13442814 |
P2093 | author name string | Constance E Brinckerhoff | |
Jessica S Blackburn | |||
P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 | ||
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing | Q28131793 | ||
PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism | Q28264379 | ||
Matrix metalloproteinases and the regulation of tissue remodelling | Q29618747 | ||
Matrix metalloproteinases: a review | Q29620220 | ||
Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices. | Q31954451 | ||
RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis | Q40050593 | ||
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells | Q40149235 | ||
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. | Q40459317 | ||
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signaling | Q40548011 | ||
Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. | Q40880348 | ||
Fragments of human fibroblast collagenase. Purification and characterization | Q41874987 | ||
Molecular interpretation of ERK signal duration by immediate early gene products | Q42812329 | ||
Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase | Q43750913 | ||
Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activation | Q45038622 | ||
MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matrices | Q46471271 | ||
Thrombin Induces Proteinase-activated Receptor-1 Gene Expression in Endothelial Cells via Activation of Gi-linked Ras/Mitogen-activated Protein Kinase Pathway | Q62944825 | ||
Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding | Q71543614 | ||
Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substrates | Q72189792 | ||
Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist | Q73045053 | ||
Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo | Q73575612 | ||
Complex role of matrix metalloproteinases in angiogenesis | Q77474882 | ||
Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation | Q80050896 | ||
Substrate specificities of matrix metalloproteinase 1 in PAR-1 exodomain proteolysis | Q80546519 | ||
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype | Q33323527 | ||
VEGFs, receptors and angiogenesis | Q33644265 | ||
Proteinase-activated receptors. | Q33947141 | ||
Effects of thrombin/thrombosis in angiogenesis and tumour progression | Q34017818 | ||
Mechanism of thrombin-induced angiogenesis | Q34129745 | ||
Interstitial collagenases as markers of tumor progression | Q34130340 | ||
International Union of Pharmacology. XXVIII. Proteinase-activated receptors | Q34130822 | ||
Matrix metalloproteinases in tumor invasion and metastasis | Q34136635 | ||
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis | Q34249064 | ||
Treatment of cancer with anticoagulants: rationale in the treatment of melanoma | Q34261285 | ||
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels | Q34275284 | ||
Role of thrombin in angiogenesis and tumor progression | Q34307545 | ||
Angiogenesis assays: a critical overview | Q35036728 | ||
Tissue factor, thrombin, and cancer | Q35217277 | ||
Role of Protease-activated Receptors in the Vascular System | Q35562739 | ||
Protease-activated receptors: contribution to physiology and disease | Q35715253 | ||
Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma | Q35741707 | ||
The chemokine system -- a major regulator of angiogenesis in health and disease | Q35962626 | ||
Metalloproteinases and their inhibitors in tumor angiogenesis | Q36053766 | ||
Collagenases in cancer | Q36076488 | ||
Targeting the stromal fibroblasts: a novel approach to melanoma therapy | Q36334912 | ||
The dynamic roles of angiopoietins in tumor angiogenesis | Q36429528 | ||
Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. | Q36538338 | ||
In vivo models of angiogenesis | Q36600421 | ||
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype | Q36650343 | ||
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer | Q36753998 | ||
In vitro models of angiogenesis | Q36764520 | ||
Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you? | Q36892551 | ||
Tumor promotion by tumor-associated macrophages | Q36908944 | ||
Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1. | Q37000497 | ||
Tumor stroma and regulation of cancer development | Q37014752 | ||
Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo model | Q37169198 | ||
Integrins in angiogenesis and lymphangiogenesis | Q37170752 | ||
Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells. | Q38328320 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | angiogenesis | Q539568 |
endothelium | Q111140 | ||
P304 | page(s) | 1736-1746 | |
P577 | publication date | 2008-11-06 | |
P1433 | published in | The American Journal of Pathology | Q4744259 |
P1476 | title | Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis | |
P478 | volume | 173 |
Q83979511 | A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer |
Q37459121 | A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis |
Q34354569 | BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity |
Q37322052 | Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis |
Q38046798 | Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? |
Q30499994 | Cathepsin L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration |
Q35231067 | Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling |
Q34770486 | Coagulation and autoimmunity in scleroderma interstitial lung disease. |
Q42379523 | Complement 3 is involved with ventilator-induced lung injury |
Q57026320 | Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats |
Q37394572 | Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma. |
Q46360418 | Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva |
Q34301563 | Expression of protease-activated receptor 1 and 2 and anti-tubulogenic activity of protease-activated receptor 1 in human endothelial colony-forming cells |
Q38789342 | Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1. |
Q37453552 | Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1. |
Q34457039 | Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis. |
Q36542806 | Matrix metalloproteases and PAR1 activation |
Q37439490 | Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer |
Q39486488 | Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma |
Q36508733 | Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells |
Q36960275 | Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling |
Q38188373 | Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression. |
Q34488791 | Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP function |
Q39093865 | Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1). |
Q52721277 | Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis. |
Q41941690 | PTEN plays an important role in thrombin-mediated lung cancer cell functions |
Q33665623 | Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions |
Q87829037 | Prognostic value of matrix metalloprotease-1/protease-activated receptor-1 axis in patients with prostate cancer |
Q37352763 | Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1 |
Q59591342 | Proteases in Melanoma |
Q50129702 | Proteinases and their receptors in inflammatory arthritis: an overview |
Q38966192 | Proteinases, Their Extracellular Targets, and Inflammatory Signaling. |
Q35083186 | Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy |
Q37873891 | Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury. |
Q33870369 | Signal transduction by protease-activated receptors |
Q84716359 | Stromal collagenase in melanoma: a vascular connection |
Q37862154 | Tangled fibroblasts in tumor-stroma interactions |
Q37308167 | The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells |
Q36405269 | The MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor Cells |
Q34503022 | The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model |
Q51723599 | Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin. |
Q43963683 | Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells |
Q37451950 | Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling |
Q37903955 | Tissue factor and cell signalling in cancer progression and thrombosis |
Q37125854 | Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination |
Q51720742 | Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy. |
Q42219763 | β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells. |
Search more.